Newsletter / Paid-only Countries wrestle with regulatory data, trade secrets and tech transfer: TRIPS Waiver discussions at WTO By Priti Patnaik / 9 Jul 2021
Newsletter / Paid-only Vaccines falling through the cracks in the regulatory mosaic By Priti Patnaik / 6 Jul 2021
Newsletter / Paid-only The clock is ticking on securing WHO's finances; TRIPS Waiver update By Priti Patnaik / 2 Jul 2021
Newsletter / Paid-only TRIPS Talks: Interview with João Aguiar Machado, EU Ambassador to the WTO By Priti Patnaik / 29 Jun 2021
Newsletter / Paid-only A Moment of Reckoning for the COVAX Facility; EU's Tweaks to Compulsory Licensing at the WTO By Priti Patnaik / 25 Jun 2021
Newsletter / Paid-only South Africa bags first mRNA tech transfer hub; The EU's push for a declaration at the WTO By Priti Patnaik / 22 Jun 2021
Newsletter / Paid-only The importance of the scope of the TRIPS Waiver. Talks off to a tough start at WTO By Priti Patnaik / 18 Jun 2021
Newsletter / Paid-only Essay: The Economics of Health For All; Announcing the Geneva Health Files Summer Fellows By Priti Patnaik / 15 Jun 2021
Newsletter / Paid-only Stage set for TRIPS Talks: An intense summer of negotiations for Geneva By Priti Patnaik / 11 Jun 2021
Newsletter / Paid-only The demand for vaccine indemnity from countries & the terms of COVAX By Priti Patnaik / 8 Jun 2021
